Arvinas, Inc. (ARVN)
7.29
-0.01
(-0.14%)
USD |
NASDAQ |
Oct 26, 12:07
Arvinas Enterprise Value : -83.01M for Oct. 23, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 23, 2026 | -83.01M |
| October 22, 2026 | -55.58M |
| October 21, 2026 | -66.36M |
| October 20, 2026 | -59.50M |
| October 19, 2026 | -85.62M |
| October 16, 2026 | -104.56M |
| October 15, 2026 | -92.15M |
| October 14, 2026 | -114.35M |
| October 13, 2026 | -113.05M |
| October 12, 2026 | -73.22M |
| October 09, 2026 | -60.81M |
| October 08, 2026 | -69.30M |
| October 07, 2026 | -73.22M |
| October 06, 2026 | -82.36M |
| October 05, 2026 | -72.56M |
| October 02, 2026 | -75.83M |
| October 01, 2026 | -74.52M |
| September 30, 2026 | -54.60M |
| September 29, 2026 | -69.95M |
| September 28, 2026 | -69.30M |
| September 25, 2026 | -64.07M |
| September 24, 2026 | -51.01M |
| September 23, 2026 | -48.40M |
| September 22, 2026 | -3.997M |
| September 21, 2026 | -17.71M |
| Date | Value |
|---|---|
| September 18, 2026 | -18.36M |
| September 17, 2026 | -17.06M |
| September 16, 2026 | -26.85M |
| September 15, 2026 | -20.32M |
| September 14, 2026 | -11.18M |
| September 11, 2026 | -7.915M |
| September 10, 2026 | 9.063M |
| September 09, 2026 | 12.33M |
| September 08, 2026 | 33.22M |
| September 04, 2026 | 53.47M |
| September 03, 2026 | 48.24M |
| September 02, 2026 | 66.53M |
| September 01, 2026 | 46.28M |
| August 31, 2026 | 41.06M |
| August 28, 2026 | 39.75M |
| August 27, 2026 | 43.67M |
| August 26, 2026 | 48.90M |
| August 25, 2026 | 67.18M |
| August 24, 2026 | 50.20M |
| August 21, 2026 | 51.83M |
| August 20, 2026 | 29.63M |
| August 19, 2026 | 72.40M |
| August 18, 2026 | 44.98M |
| August 17, 2026 | 41.06M |
| August 14, 2026 | 26.04M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Cocrystal Pharma, Inc. | 12.20M |
| CNBX Pharmaceuticals, Inc. | 1.305M |
| Fulcrum Therapeutics, Inc. | -32.83M |
| Definium Therapeutics, Inc. | 3.745B |
| LeonaBio, Inc. | -4.889M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 169.40M |
| Revenue (Quarterly) | 249.70M |
| Total Expenses (Quarterly) | 80.30M |
| EPS Diluted (Quarterly) | 2.578 |
| Gross Profit Margin (Quarterly) | 95.92% |
| Profit Margin (Quarterly) | 67.84% |
| Earnings Yield | 2.20% |
| Normalized Earnings Yield | 3.001 |